Brief: Processa Pharmaceuticals Reverse Stock Split Intended To Regain Compliance With Minimum Bid Price Requirement And Continued Listing On Nasdaq

Processa Pharmaceuticals

18/01/2024 12:53

Jan 18 (Reuters) - Processa Pharmaceuticals Inc
 PCSA.O :
    * PROCESSA PHARMACEUTICALS TO EFFECT A 1-FOR-20 REVERSE
STOCK
SPLIT
    * PROCESSA PHARMACEUTICALS - CO'S COMMON STOCK WILL BEGIN
TRADING
ON A REVERSE STOCK SPLIT-ADJUSTED BASIS AT OPENING OF MARKET ON
MONDAY, JAN 22, 2024
    * PROCESSA PHARMACEUTICALS: REVERSE STOCK SPLIT INTENDED FOR
CO TO
REGAIN COMPLIANCE WITH MINIMUM BID PRICE REQUIREMENT FOR
CONTINUED LISTING ON NASDAQ

Source text for Eikon:  ID:nGNX1TFB6v 
Further company coverage:  PCSA.O 

 ((Reuters.Briefs@thomsonreuters.com;))